Scientists in the US have managed to create early-stage human embryos from DNA contained in skin cells, a feat being described as one of the most striking developments in reproductive science for decades. According to BBC News, the team at Oregon Health & Science University reprogrammed skin cells into eggs, fertilised them with sperm, and successfully grew some into blastocysts, or embryos that reach the six-day stage of development.
The method combines nuclear transfer, a technique long associated with cloning, with innovative reprogramming designed to mimic how a natural egg discards half its chromosomes. Normally, skin cells carry a full set of 46 chromosomes. The scientists replaced the nucleus of a donor egg with the nucleus from a skin cell, then induced a kind of “artificial meiosis” that stripped the count back down to 23. The reprogrammed eggs were then fertilised using standard IVF, and while most failed due to chromosomal abnormalities, a small percentage developed normally for nearly a week.
A breakthrough in fertility science
For decades, researchers have sought ways to make reproductive cells from ordinary tissue. Early experiments in mice demonstrated that stem cells could be coaxed into gametes, but applying this to humans has been far more complex. In their report on the findings, The Guardian noted that this is the first time scientists have produced human embryos using genetic material that originated from skin, a milestone that could transform how infertility is treated in the future.
The potential applications are vast. Women who can no longer produce viable eggs because of age or medical treatment could, in theory, use cells from their own skin to conceive. Same-sex male couples, who currently have no biological route to parenthood together, could one day generate eggs from one partner’s tissue to be fertilised by the other’s sperm. Fertility preservation might also become simpler if reproductive potential is no longer tied to harvesting and freezing eggs at a young age.
But as the researchers themselves cautioned, these scenarios are still far in the distance. Success rates remain very low, with only around 9% of the reprogrammed eggs reaching the blastocyst stage. Most carried chromosomal errors that would prevent further development.
Safety, ethics, and the shadow of misuse
Alongside the promise comes a long list of concerns. The chromosomal instability seen in most embryos is a major barrier, and the scientists stressed that the technique is not remotely ready for clinical use. Writing about the experiment, the Financial Times pointed out that any attempt to implant such embryos into a uterus would carry huge risks of miscarriage or developmental disorders.
Ethical issues also loom large. Because the DNA comes from skin cells, in theory it could be harvested without consent. Strict regulations already govern reproductive research, but critics warn that safeguards must keep pace with new technologies. There are also broader questions about whether this could pave the way for so-called “designer embryos,” with parents selecting traits through genetic editing once embryos can be generated in abundance.
The memory of past scandals in the field weighs heavily. The case of the Chinese scientist He Jiankui, who in 2018 edited the genomes of human embryos without approval and led to global condemnation, has become a touchstone for how not to proceed. Regulators are now wary of any rush toward clinical application without careful oversight.
Where the science goes from here
The team’s next steps involve refining the reprogramming process so that more embryos develop with the correct number of chromosomes, and testing in animal models to assess long-term safety. Other laboratories are pursuing related strategies, including in vitro gametogenesis, which aims to create both eggs and sperm from stem cells. AP News noted that while mouse models have shown the concept can work, translating those findings into humans remains fraught with complexity.
If the hurdles can be overcome, the implications are extraordinary. Infertility could be treated without invasive egg collection. Same-sex couples could share a genetic link to their children. And women might no longer face such sharp age limits on fertility if eggs could be created from their own tissue later in life. But all of this depends on years of careful research, ethical debate and international cooperation.
For now, the embryos created in Oregon will not be implanted. They will be studied under strict legal limits that forbid growth beyond 14 days. Even at this early stage, however, they provide scientists with a valuable window into how human development begins, and how errors emerge that cause miscarriage or disease. That knowledge alone could lead to better IVF outcomes and a deeper understanding of early pregnancy loss.
The experiment has shown what is possible: that DNA taken from an ordinary skin cell can, under the right conditions, be reset into something that looks and acts like an egg. Whether that becomes a tool to reshape human reproduction, or remains a scientific curiosity, will depend on what researchers, regulators, and society decide to do next.